| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alemtuzumab induced acquired hemophilia A in multiple sclerosis: a case report
|
Fawaz, Hassan
|
|
|
102 |
11 |
p. 3271-3273
|
article
|
| 2 |
Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt
|
Youssef, Mervat A M
|
|
|
102 |
11 |
p. 2997-3006
|
article
|
| 3 |
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
|
Wang, Shixuan
|
|
|
102 |
11 |
p. 3251-3259
|
article
|
| 4 |
A pilot study of cord blood-derived natural killer cells as maintenance therapy after autologous hematopoietic stem cell transplantation
|
Wu, Yuling
|
|
|
102 |
11 |
p. 3229-3237
|
article
|
| 5 |
Association between ABO blood group/genotype and COVID-19 in a Japanese population
|
Kusumoto, Tatsuya
|
|
|
102 |
11 |
p. 3239-3249
|
article
|
| 6 |
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study
|
Wu, Meng
|
|
|
102 |
11 |
p. 3185-3193
|
article
|
| 7 |
Bleeding pattern and consumption of factor VIII concentrate in adult patients with haemophilia A without inhibitors in the Czech Republic between 2013 and 2021 (Czech National Haemophilia Programme registry data)
|
Romanová, Gabriela
|
|
|
102 |
11 |
p. 3261-3270
|
article
|
| 8 |
Bleeding risk assessment in immune thrombocytopenia
|
Mishra, Kundan
|
|
|
102 |
11 |
p. 3007-3014
|
article
|
| 9 |
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
|
Gong, Yuqi
|
|
|
102 |
11 |
p. 3153-3165
|
article
|
| 10 |
Chronic neutrophilic leukemia with JAK2 mutation: is it true chronic neutrophilic leukemia?
|
Gao, Jiapei
|
|
|
102 |
11 |
p. 3275-3276
|
article
|
| 11 |
Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey
|
Sun, Xing-Hua
|
|
|
102 |
11 |
p. 3177-3184
|
article
|
| 12 |
Daratumumab—a novel treatment strategy in relapsed/refractory acute leukemia
|
Borah, Pronamee
|
|
|
102 |
11 |
p. 3291-3293
|
article
|
| 13 |
Delay in treatment of adult hemophagocytic lymphohistiocytosis is associated with worse in-hospital outcomes
|
Abdelhay, Ali
|
|
|
102 |
11 |
p. 2989-2996
|
article
|
| 14 |
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia
|
Kimura, Hiroyuki
|
|
|
102 |
11 |
p. 3103-3113
|
article
|
| 15 |
Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring
|
Coe-Eisenberg, Taylor D.
|
|
|
102 |
11 |
p. 3133-3141
|
article
|
| 16 |
Excellent outcome of stem cell transplantation for sickle cell disease
|
Vallée, Tanja
|
|
|
102 |
11 |
p. 3217-3227
|
article
|
| 17 |
Generic ibrutinib a potential cost-effective strategy for the first-line treatment of chronic lymphocytic leukaemia
|
Hegde, Naveen C
|
|
|
102 |
11 |
p. 3125-3132
|
article
|
| 18 |
Gilteritinib and the risk of intracranial hemorrhage: a case series of a possible, under-reported side effect
|
Perrone, Salvatore
|
|
|
102 |
11 |
p. 3025-3030
|
article
|
| 19 |
Hemophagocytosis by multinucleated leukemic blasts, basophilia, and micromegakaryocytes in AML with TLS::ERG
|
Huang, Xingqin
|
|
|
102 |
11 |
p. 3279-3281
|
article
|
| 20 |
Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
|
Kim, Moonho
|
|
|
102 |
11 |
p. 3167-3175
|
article
|
| 21 |
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
|
Xu, Jingyu
|
|
|
102 |
11 |
p. 3195-3204
|
article
|
| 22 |
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies
|
Avivi, Irit
|
|
|
102 |
11 |
p. 3075-3081
|
article
|
| 23 |
Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis
|
Kuehl, Rea
|
|
|
102 |
11 |
p. 3091-3102
|
article
|
| 24 |
Prediction nomogram based on 18F-FDG PET/CT and clinical parameters for patients with diffuse large B-cell lymphoma
|
Peng, Xiaojuan
|
|
|
102 |
11 |
p. 3115-3124
|
article
|
| 25 |
Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study
|
Infante, Joana
|
|
|
102 |
11 |
p. 3031-3037
|
article
|
| 26 |
Quadruple stem cells transplantation of haploidentical bone marrow and PBSCs supporting by third-party umbilical cord blood and MSCs achieved excellent outcomes
|
Luo, Chengxin
|
|
|
102 |
11 |
p. 3285-3287
|
article
|
| 27 |
Real-world outcomes and prognostic factors among patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation
|
Wang, Qingya
|
|
|
102 |
11 |
p. 3061-3074
|
article
|
| 28 |
Recurrent arterial thrombosis as the primary symptom in a patient with polycythemia vera
|
Wen, Jia-hao
|
|
|
102 |
11 |
p. 3289-3290
|
article
|
| 29 |
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile
|
Guarnera, Luca
|
|
|
102 |
11 |
p. 3015-3023
|
article
|
| 30 |
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case–control study in the International PNH Registry
|
Höchsmann, Britta
|
|
|
102 |
11 |
p. 2979-2988
|
article
|
| 31 |
Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study
|
Jiang, Shan
|
|
|
102 |
11 |
p. 3205-3216
|
article
|
| 32 |
“Sandwich” protocol based on modified SMILE regimen for children with newly extranodal NK/T cell lymphoma, nasal type: a single-arm, single-center clinical study
|
Shen, Cheng-qi
|
|
|
102 |
11 |
p. 3143-3152
|
article
|
| 33 |
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
|
Croucher, Peter J P
|
|
|
102 |
11 |
p. 3049-3059
|
article
|
| 34 |
Successful treatment by CAR T-cells in multi-refractory mantle cell lymphoma with central nervous system involvement
|
Caillet, Adrien
|
|
|
102 |
11 |
p. 3295-3297
|
article
|
| 35 |
Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation
|
Kosugi, Shigeki
|
|
|
102 |
11 |
p. 3277-3278
|
article
|
| 36 |
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation
|
Louzao, María
|
|
|
102 |
11 |
p. 3283-3284
|
article
|
| 37 |
Treatment of refractory or relapsed myelodysplastic neoplasms with luspatercept: a multicenter Chinese study
|
Zhang, Zhuxin
|
|
|
102 |
11 |
p. 3039-3047
|
article
|
| 38 |
Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group
|
von Tresckow, Julia
|
|
|
102 |
11 |
p. 3083-3090
|
article
|
Journal description